An analysis of watchful waiting for clinically localized prostate cancer

The Journal of Urology
G D SteinbergC B Brendler

Abstract

We reviewed recent series of watchful waiting for prostate cancer to place this management strategy in appropriate perspective We reviewed the literature and analyzed the 9 articles on watchful waiting published in leading medical journals in the last decade. Watchful waiting is probably the best treatment option for men with well and perhaps moderately differentiated, low volume prostate cancer who have a life expectancy of less than 10 years. However, the conclusions derived from watchful waiting studies of older men cannot and should not be applied to younger, healthier men or to those with more advanced or aggressive disease. If treated ineffectively, many of these men will die of prostate cancer. Most men with prostate cancer who have a life expectancy greater than 10 to 15 years should be treated with curative intent.

References

Feb 1, 1992·British Journal of Urology·J AdolfssonT Löwhagen
Feb 25, 1991·Cancer·W F WhitmoreI M Thompson
Jan 1, 1987·Urologia Internationalis·B MoskovitzD Richter Levin
Apr 1, 1982·The Journal of Urology·J S ElderP C Walsh
Sep 1, 1982·The Journal of Urology·P C Walsh, P J Donker
Feb 2, 1994·JAMA : the Journal of the American Medical Association·J I EpsteinC B Brendler
Aug 23, 1995·JAMA : the Journal of the American Medical Association·P C AlbertsenJ Fine
Nov 1, 1994·The Journal of Urology·J R BeckB J Miles
Jan 27, 1994·The New England Journal of Medicine·G W ChodakJ Warner
May 26, 1993·JAMA : the Journal of the American Medical Association·G L Lu-YaoJ E Wennberg
Feb 12, 1997·JAMA : the Journal of the American Medical Association·J E JohanssonH O Adami
Jun 1, 1997·The Journal of Urology·H B CarterJ I Epstein

❮ Previous
Next ❯

Citations

Oct 6, 2005·Der Urologe. Ausg. A·M GraefenH Huland
Dec 20, 2005·International Urology and Nephrology·Hatzimouratidis Konstantinos
Apr 7, 2010·Journal of Gastrointestinal Cancer·Mohammad Atif Khan, G R Verma
Nov 11, 2003·Critical Reviews in Oncology/hematology·Sergio VillaPatrizia Olmi
Feb 13, 2001·Urologic Oncology·W A. SeeM Wirth
Jul 15, 2003·Urologic Oncology·I KlimbergW W Smith
Jan 6, 2006·The Cancer Journal·Loren K Mell, Arno J Mundt
Jun 1, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Matthew R CooperbergPeter R Carroll
Dec 7, 2010·Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie·L SalomonUNKNOWN Oncology Committee of the French Association of Urology (CCAFU)
Feb 4, 2014·Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie·L SalomonUNKNOWN Les membres du CCAFU
May 13, 2008·Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie·A Benchikh El FegounP Beuzeboc
Mar 9, 2005·International Journal of Radiation Oncology, Biology, Physics·Stephanie T H PeetersPeter C M Koper
Feb 10, 2004·The Journal of Urology·Hongyan WuDouglas Soderdahl
Nov 29, 2005·Critical Reviews in Oncology/hematology·Sergio BracardaGeorg Bartsch
Jul 12, 2002·The Urologic Clinics of North America·Mark A NelsonJames R Marshall
Aug 21, 2002·Expert Opinion on Pharmacotherapy·Paul F Schellhammer
Oct 29, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Corey A CarterJudd W Moul
Oct 16, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Urs E StuderDaniel Dietrich
Oct 21, 2004·The Journal of the Royal Society for the Promotion of Health·Emad SiddiquiJames Gelister
Nov 23, 2000·Journal of General Internal Medicine·E S Holmboe, J Concato
Apr 28, 2001·Cancer Control : Journal of the Moffitt Cancer Center·B Hoff, J M Pow-Sang
Sep 30, 1999·The Medical Clinics of North America·L E Hahnfeld, T D Moon
Dec 25, 2007·Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie·Michel SouliéArnauld Villers

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.